Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia.

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Abstract Text:

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of the National Cancer Institute

VOLUME: 100

Page Numbers: E1

Journal Abbreviation: J. Natl. Cancer Inst.

ISSN: 1460-2105

DAY: 29

MONTH: 07

YEAR: 2008

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503089

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia.

AFFILIATION: Department of Internal Medicine 1, Cochrane Haematological Malignancies Group, University Hospital of Cologne, Cologne, Germany. christine.herbst@uk-koeln.de

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Natl Cancer Inst

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia Related Publications

• Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
• Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.
• Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma.
• Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
• Control of visually guided behavior by distinct populations of spinal projection neurons.
• Current treatment strategies of the German Hodgkin Study Group (GHSG).
• Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies.
• Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemia.
• Escape behavior elicited by single, channelrhodopsin-2-evoked spikes in zebrafish somatosensory neurons.
• Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?
• Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
• Genetic Variants of FTO Influence Adiposity, Insulin Sensitivity, Leptin Levels, and Resting Metabolic Rate in the Quebec Family Study.
• Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
• High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults.
• Hodgkin's disease. Future treatment strategies: fact or fiction?
• Human Leukocyte Antigen-B-Associated Transcript 3 Is Released from Tumor Cells and Engages the NKp30 Receptor on Natural Killer Cells.
• Immunotherapy of Hodgkin's lymphoma.
• K45R variant of squalene synthase increases total cholesterol levels in two study samples from a French Canadian population.
• Lymphocyte-predominant and classical Hodgkin's lymphoma--comparison of outcomes.
• Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
• Non-Hodgkin's Lymphoma: A Review of Immunotherapeutic Approaches to Treatment.
• Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.
• [Antibiotic therapy of endocarditis lenta.]
• [Effect of intraoperative blood loss on the function of natural killer cells in tumors of the upper gastrointestinal tract]
• [Thoracic surgery emergencies in early childhood]